WASHINGTON (MedPage Today) — The Obama administration and congressional Republicans both noted the 6-month anniversary of the health reform law on Wednesday, but with markedly different takes on the milestone.
No Comments »
Filed under: General Health News
BALTIMORE (MedPage Today) — A Medicare advisory committee has voted that there is not enough evidence to warrant off-label use of recombinant human bone morphogenetic protein, or BMP, for bone surgery.
No Comments »
Filed under: General Health News
(MedPage Today) — A targeted telephone-based care-management program demonstrated potential for reducing healthcare costs by reaching out to more patients with predicted high healthcare expenses, results of a large randomized study showed.
No Comments »
Filed under: General Health News
(MedPage Today) — The controversial diabetes drug rosiglitazone (Avandia) can remain on the market, but new patients can receive it only if their blood sugar can’t be controlled with pioglitazone (Actos), the FDA announced today.
No Comments »
Filed under: Pharmacy News
Tolerx, Inc., a biopharmaceutical company developing novel therapies to treat autoimmune diseases and cancer by modulating T cell activity, today announced the presentation of preclinical research describing the mechanism of action of otelixizumab at the 46th Annual Meeting of the European Association for the Study of Diabetes (EASD). In addition, Tolerx also announced that the [...]
No Comments »
Filed under: Pharmacy News
ZIOPHARM Oncology, Inc. announced today that the United States Food & Drug Administration (FDA) has granted Orphan Drug Designation to darinaparsin (Zinapar™ or ZIO-101) for the treatment of peripheral T-cell Lymphoma (PTCL). The United States Orphan Drug Act of 1983 was created to provide incentives for companies to develop and market treatments for diseases or [...]
No Comments »
Filed under: Pharmacy News
New data from the linagliptin late stage clinical trial programme were presented this week at the 46th Annual Meeting of the European Association for the Study of Diabetes (EASD).
No Comments »
Filed under: Pharmacy News
Athersys, Inc. announced at its presentation at the Transvascular Cardiovascular Therapeutics (TCT) Conference held in Washington, D.C., updated results from its phase I clinical trial of MultiStem, its allogeneic cell therapy product, administered to individuals following acute myocardial infarction (AMI).
No Comments »
Filed under: Pharmacy News
Vaxonco Inc., a Korean company specializing in peptide-based vaccines and Ichor Medical Systems (Ichor), whose advanced TriGrid™ Delivery System (TriGrid™) is being tested worldwide for its ability to enhance delivery of DNA drugs and vaccines, announced today the initiation of a Phase I clinical trial to evaluate a novel DNA-based polyepitope vaccine against malaria.
No Comments »
Filed under: Pharmacy News
AstraZeneca’s new oral syk inhibitor, fostamatinib (R788), recently in-licensed from Rigel Pharmaceuticals, Inc., significantly improved outcomes of patients with rheumatoid arthritis who responded inadequately to ongoing treatment with methotrexate, according to phase II study data published in The New England Journal of Medicine today.
No Comments »
Filed under: Pharmacy News
